James Kory Wentworth Net Worth & Insider Trades
James Kory Wentworth - Principal Accounting Officer, Bluebird Bio, Inc
What is James Kory Wentworth's Net Worth?
The current estimated net worth of Bluebird Bio, Inc's Principal Accounting Officer, James Kory Wentworth, is estimated to be about $1.43M . James Kory Wentworth owns about 9,512 units of Bluebird Bio, Inc common stock. In the last 2 years at Bluebird Bio, Inc, James Kory Wentworth has sold an estimated value of $224.46K worth.
What is James Kory Wentworth's Past Insider Trading?
James Kory Wentworth's largest sale order was 388 units , worth over $39.98K on December 21, 2018. In total, James Kory Wentworth has made about 14 transactions over 2 years of their time at Bluebird Bio, Inc. James Kory Wentworth usually trades in January and June, with the busiest year in 2019. The most recent transaction was a sale order of 82 units , worth over $5K on August 5, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
JAMES KORY WENTWORTH
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is James Kory Wentworth's' Mailing Address?
- Mailing address is 60 Binney Street C/o Bluebird Bio, Inc. Cambridge MA 02142 MA
What are Bluebird Bio, Inc's Past Insider Trades?
Bluebird Bio, Inc's most recent insider trade came on November 3, 2023 by Andrew Obenshain who sold 807 units worth $2.55K . In the last 10 years, insiders at Bluebird Bio, Inc have sold an estimated value of $305.13M and bought an estimated value of $20.38M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are David Davidson, Chief Medical Officer, Philip Gregory, Chief Scientific Officer, and Jeffrey Walsh, Chief Strategy Officer .
bluebird bio, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |